Fundz

Xencor Appoints Bart Cornelissen as Senior Vice President and Chief Financial Officer

PUBLIC · XNCRApr 09, 2024

Position

Chief Financial Officer

Company

Xencor

Bart Cornelissen
PasadenaBiotechnologyHealth CareTherapeuticsBiopharma

Description

Xencor, Inc. announced the appointment of Bart Cornelissen to senior vice president and chief financial officer. Mr

Quick answer

Xencor Appoints Bart Cornelissen as Senior Vice President and Chief Financial Officer (April 9, 2024). Xencor is based in Pasadena, California, United States.

Who is the new Chief Financial Officer at Xencor?
Xencor named Bart Cornelissen Chief Financial Officer, announced April 9, 2024.
What did Xencor announce on April 9, 2024?
Xencor, Inc. announced the appointment of Bart Cornelissen to senior vice president and chief financial officer.
What does Xencor do?
Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of patients with cancer and other serious diseases.
Where is Xencor based?
Xencor is based in Pasadena, California, United States.
Which similar companies made leadership changes around the same time?
Acadia Pharmaceuticals (April 2, 2024), Dynavax Technologies (April 1, 2024), Aculys Pharma (April 1, 2024) and Verastem Oncology (April 18, 2024) also announced leadership changes within 45 days of Xencor.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biopharma

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Xencor, and when

A new leader at Xencor brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Xencor raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Xencor, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Xencor. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Xencor

Location

Pasadena, California, United States

About

Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of patients with cancer and other serious diseases. More than 20 candidates engineered with Xencor's XmAb® technology are in clinical development, and three XmAb medicines are marketed by partners. Xencor's XmAb engineering technology enables small changes to a protein's structure that result in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Xencor changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Xencor's next move

Learn about Strategic plan

Xencor changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.